Skip to content 
Search

Latest Stories

Analysts upbeat about IPO-bound Oxford Nanopore's valuation

Analysts upbeat about IPO-bound Oxford Nanopore's valuation

AS Oxford Nanopore confirmed its plans for stock market floatation later this year, market analysts are upbeat about its potential valuation.

The biotech company was valued at £2.4 billion when it raised £195 million in May this year and analysts at Jefferies believe it has the potential to reach a valuation of £3.9bn.


Oxford Nanopore would have “scarcity value” as one of the few biotech companies listing on London's stock market, Julian Roberts of Jefferies told The Telegraph.

He said the company, which is yet to make profits, could have fetched a higher valuation if it were to list on the Nasdaq.

In a filing to the London Stock Exchange, the genome sequencing company said it intends to have a free float of “at least 25 per cent” of its share capital.

The initial public offering (IPO) would comprise new shares to be issued by the company and an offer of existing shares, it said.

Among the potential risks, the biotech company warned that rivals could attempt to call into question the reputation of its chief executive Gordon Sanghera.

Referring to a patent case in an American court involving Sanghera, the company said, “litigation counterparties will attempt to impugn the integrity of the group and/or its management when involved in intellectual property litigation”.

When Sanghera was director of research and development for the diabetes vertical of Abbott Laboratories, a California court judge found him guilty of inequitable conduct, The Times reported.

It was found in 2008 that there was “materially misleading omission” in his direct representations to the US Patent and Trademark Office.

Sanghera, 60, holds 10.4 million shares in Oxford Nanopore.

Based at the Oxford Science Park, it also has offices in Shanghai, Beijing and San Francisco, employing more than 600 people, 500 of them in the UK.

Founded in 2005 as a spin-out from the University of Oxford, the company provides DNA/RNA sequencing technology for biomedical, pathogen, plant and animal scientific research, infectious diseases and food and agriculture sectors.

More For You

Bangladesh seeks US deal to shield garment industry from tariffs

Workers are engaged at their sewing stations in a garment factory in Savar, on the outskirts of Dhaka, on April 9, 2025. (Photo by MUNIR UZ ZAMAN/AFP via Getty Images)

Bangladesh seeks US deal to shield garment industry from tariffs

BANGLADESH, the world's second-biggest garment manufacturer, aims to strike a trade deal with the US before Donald Trump's punishing tariffs kick in next week, said the country's top commerce official.

Dhaka is proposing to buy Boeing planes and boost imports of US wheat, cotton and oil in a bid to reduce the trade deficit, which Trump used as the reason for imposing painful levies in his "Liberation Day" announcement.

Keep ReadingShow less
UK business district
The Canary Wharf business district including global financial institutions in London.
Getty Images

Bond yields ease following Starmer’s support for Reeves

THE COST of UK government borrowing fell on Thursday, partially reversing the rise seen after Chancellor Rachel Reeves became emotional during Prime Minister’s Questions.

The yield on 10-year government bonds dropped to 4.55 per cent, down from 4.61 per cent the previous day. The pound also recovered slightly to $1.3668 (around £1.00), though it did not regain all its earlier losses.

Keep ReadingShow less
modi-trump-getty
Modi shakes hands with Trump before a meeting at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)
Getty Images

Indian exporters watch closely as Trump says trade deal with India likely

THE US could reach a trade deal with India that would help American companies compete more easily in the Indian market and reduce tariff rates, President Donald Trump said on Tuesday. However, he cast doubt on a similar deal with Japan.

Speaking to reporters on Air Force One, Trump said he believed India was ready to lower trade barriers, potentially paving the way for an agreement that would avoid the 26 per cent tariff rate he had announced on April 2 and paused until July 9.

Keep ReadingShow less
Kolhapuri sandal sales surge in India post Prada controversy

Customers shop for 'Kolhapuri' sandals, an Indian ethnic footwear, at a store in New Delhi, India, June 27, 2025. REUTERS/Adnan Abidi

Kolhapuri sandal sales surge in India post Prada controversy

INDIAN footwear sellers and artisans are tapping into nationalist pride stoked by the Prada 'sandal scandal' in a bid to boost sales of ethnic slippers with history dating back to the 12th century, raising hopes of reviving a struggling craft.

Sales are surging over the past week for the 'Kolhapuri' sandals that have garnered global attention after Prada sparked a controversy by showcasing similar designs in Milan, without initially crediting the footwear's origins.

Keep ReadingShow less
UK business district
The Canary Wharf business district including global financial institutions in London.
Getty Images

Economy grew 0.7 per cent in Q1 2025, fastest in a year

THE UK economy expanded at its fastest pace in a year during the first quarter of 2025, driven by a rise in home purchases ahead of a tax deadline and higher manufacturing output before the introduction of new US import tariffs.

Gross domestic product rose by 0.7 per cent in the January-to-March period, the Office for National Statistics (ONS) said, confirming its earlier estimate. This was the strongest quarterly growth since the first quarter of 2024.

Keep ReadingShow less